Mechanism of Beraprost Effects on Pulmonary Hypertension: Contribution of Cross-Binding to PGE2 Receptor 4 and Modulation of O2 Sensitive Voltage-Gated K+ Channels

Background: The purpose of this study is to elucidate mechanism(s) by which the orally active PGI2 analog, Beraprost (BPS), ameliorates pulmonary hypertension (PH). Prostaglandins are an important treatment for PH. Mechanisms of their action are not fully elucidated in relation to receptor subtype a...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Fenling Fan, Hua Tian, Jie Geng, Jizhao Deng, Ya Liu, Chunyan Chen, Songlin Zhang, Yushun Zhang, Jie Li, Hongyan Tian, Anthony M. Dart, Yuliang Zou
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2019-01-01
Collection:Frontiers in Pharmacology
Sujets:
pulmonary arterial hypertension
prostanoids
Beraprost
IP receptor
EP4 receptor
Kv channel
Accès en ligne:https://www.frontiersin.org/article/10.3389/fphar.2018.01518/full
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires